SENATE BILL 757
C4, J1 5lr2660
SB 142/24 – FIN CF HB 1007
By: Senator A. Washington
Introduced and read first time: January 27, 2025
Assigned to: Finance
A BILL ENTITLED
1 AN ACT concerning
2 Genetic Testing – Prohibition on Disability, Life, and Long–Term Care
3 Insurance
4 (Genetic Testing Protection Act)
5 FOR the purpose of prohibiting insurance carriers that offer life insurance, long–term care
6 insurance, or disability insurance policies or contracts from taking certain actions
7 relating to coverage based on whether an applicant or a policy or contract holder has
8 requested or undergone genetic testing or the results of the genetic testing; and
9 generally relating to genetic testing.
10 BY adding to
11 Article – Insurance
12 Section 27–909.1
13 Annotated Code of Maryland
14 (2017 Replacement Volume and 2024 Supplement)
15 SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
16 That the Laws of Maryland read as follows:
17 Article – Insurance
18 27–909.1.
19 (A) (1) IN THIS SECTION THE FOLLOWING WORDS HAVE THE MEANINGS
20 INDICATED.
21 (2) “GENE PRODUCT” MEANS THE BIOCHEMICAL MATERIAL, EITHER
22 RNA OR PROTEIN, MADE BY A GENE.
23 (3) (I) “GENETIC INFORMATION” MEANS INFORMATION:
EXPLANATION: CAPITALS INDICATE MATTER ADDED TO EXISTING LAW.
[Brackets] indicate matter deleted from exist in g l aw . *sb0757*

2 SENATE BILL 757
1 1. DERIVED FROM A GENETIC TEST ABOUT
2 CHROMOSOMES, GENES, OR GENE PRODUCTS THAT MAY DERIVE FROM AN
3 INDIVIDUAL OR A FAMILY MEMBER;
4 2. NOT OBTAINED FOR DIAGNOSTIC OR THERAPEUTIC
5 PURPOSES; AND
6 3. OBTAINED AT A TIME WHEN THE INDIVIDUAL TO
7 WHOM THE INFORMATION RELATES IS ASYMPTOMATIC FOR THE DISEASE,
8 DISORDER, ILLNESS, OR IMPAIRMENT TO WHICH THE INFORMATION RELATES.
9 (II) “GENETIC INFORMATION” DOES NOT INCLUDE:
10 1. ROUTINE PHYSICAL MEASUREMENTS;
11 2. CHEMICAL, BLOOD, AND URINE ANALYSES THAT ARE
12 WIDELY ACCEPTED AND IN USE IN CLINICAL PRACTICE;
13 3. TESTS FOR USE OF DRUGS;
14 4. TESTS FOR THE PRESENCE OF THE HUMAN
15 IMMUNODEFICIENCY VIRUS; OR
16 5. FAMILY MEDICAL HISTORY, EXCEPT FOR FAMILY
17 GENETICS AS THEY RELATE TO A GENETIC TEST DESCRIBED IN SUBPARAGRAPH (I)1
18 OF THIS PARAGRAPH.
19 (4) “GENETIC SERVICES” MEANS HEALTH SERVICES THAT ARE
20 PROVIDED TO OBTAIN, ASSESS, OR INTERPRET GENETIC INFORMATION OR THE
21 RESULTS OF GENETIC TESTS.
22 (5) “GENETIC TEST” MEANS AN ANALYSIS OF HUMAN DNA, RNA,
23 CHROMOSOMES, PROTEINS, OR METABOLITES THAT DETECTS GENOTYPES,
24 MUTATIONS, OR CHROMOSOMAL CHANGES.
25 (6) “INSURANCE CARRIER” MEANS A COMPANY AUTHORIZED TO SELL
26 INSURANCE POLICIES IN THE STATE.
27 (B) (1) THIS SECTION APPLIES ONLY TO LIFE INSURANCE, LONG–TERM
28 CARE INSURANCE, AND DISABILITY INSURANCE POLICIES OR CONTRACTS.

SENATE BILL 757 3
1 (2) THIS SECTION DOES NOT PROHIBIT AN INSURANCE CARRIER THAT
2 OFFERS, ISSUES, OR DELIVERS A LIFE INSURANCE, LONG–TERM CARE INSURANCE,
3 OR DISABILITY INSURANCE POLICY OR CONTRACT IN THE STATE FROM:
4 (I) ACCESSING AN APPLICANT’S MEDICAL RECORD AS PART OF
5 THE APPLICATION PROCESS; OR
6 (II) CONSIDERING A MEDICAL DIAGNOSIS INCLUDED IN AN
7 INDIVIDUAL’S MEDICAL RECORD, EVEN IF THE DIAGNOSIS WAS BASED ON THE
8 RESULTS OF A GENETIC TEST.
9 (C) (1) AN INSURANCE CARRIER THAT OFFERS, ISSUES, OR DELIVERS A
10 LIFE INSURANCE, LONG–TERM CARE INSURANCE, OR DISABILITY INSURANCE
11 POLICY OR CONTRACT IN THE STATE MAY NOT:
12 (I) DENY OR LIMIT COVERAGE BASED ON WHETHER AN
13 APPLICANT OR A POLICY OR CONTRACT HOLDER HAS UNDERGONE A GENETIC TEST;
14 (II) PROHIBIT, AS A CONDITION OF CONTINUING COVERAGE, A
15 POLICY OR CONTRACT HOLDER FROM UNDERGOING A GENETIC TEST; OR
16 (III) USE A GENETIC TEST, THE RESULTS OF A GENETIC TEST,
17 GENETIC INFORMATION, OR A REQUEST FOR GENETIC SERVICES TO REJECT, DENY,
18 LIMIT, CANCEL, REFUSE TO RENEW, INCREASE THE RATES OF, AFFECT THE TERMS
19 OR CONDITIONS OF, OR OTHERWISE AFFECT A LIFE INSURANCE, LONG–TERM CARE
20 INSURANCE, OR DISABILITY INSURANCE POLICY OR CONTRACT.
21 (2) THE INSURANCE CARRIER, APPLICANT, OR POLICY OR CONTRACT
22 HOLDER MAY NOT CHANGE, WAIVE, DISCHARGE, OR TERMINATE THE PROVISIONS OF
23 PARAGRAPH (1) OF THIS SUBSECTION UNDER ANY CIRCUMSTANCES.
24 (D) THE COMMISSIONER MAY ISSUE AN ORDER UNDER §§ 4–113 AND 4–114
25 OF THIS ARTICLE OR §§ 27–501 AND 27–505 OF THIS TITLE IF THE COMMISSIONER
26 FINDS A VIOLATION OF THIS SECTION.
27 SECTION 2. AND BE IT FURTHER ENACTED, That this Act shall take effect
28 October 1, 2025.

[DELETED: :CA      5   C A G I ( F i r r o u g t o t r o t t a g B  A S  A  (  S T A() ( N ( “G”T L A,.N  ( () “G”:EN ]
[DELETED:  S    1 F A G T AS GS O G P T M D F A   2 O F D O TS    3 A A T W T I T T I R I A F T DER S S,.  () “G”:IEN    1 ;   2 ,L D E    3 ;S   4 F T P O T HS    5  M HY E F F I) ( “G SS M H S T A T ON AS O I G I O TS ( “G”D,R TT M A A O H  S PS O M T D GS,S . ( “IR  T.() ( T,HE GTE .]
[DELETED: S 3 ( S S E GTE,,– T:  () ATSS   ()IC A M D I I ALS M RD E I T D W B O T() ( A,NS S  IE LGT C IE O D I– T:  ()D O L C B O W A  () ,IPT E T   () ,IU A GT T R O G TTN T Y,T L W F ,,F E GT,E . ( T,R T E E E ,  ).() TC§§434H O          O§2125N  S A B I F E T t A s t e O]